Cstone pharmaceuticals co. ltd
WebCStone Pharmaceuticals Profile and History. CStone Pharmaceuticals, a biopharmaceutical company, researches, develops, and commercializes immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and internationally. It offers Sugemalimab, a monoclonal antibody against programmed … WebApr 6, 2024 · CStone Pharmaceuticals is a China-based investment holding company. Through its subsidiaries, the Company is primarily engaged in development, …
Cstone pharmaceuticals co. ltd
Did you know?
WebApr 6, 2024 · Uitgebreid zoeken Inloggen WebSep 30, 2024 · Sugemalimab is an investigational anti-PD-L1 monoclonal antibody discovered by CStone. Authorized by a company based in the U.S., Ligand …
WebApr 6, 2024 · CStone Pharmaceuticals ha annunciato che la National Medical Products Administration della Cina ha accettato la domanda di licenza biologica supplementare per sugemalimab in combinazione con la... Ricerca avanzata
WebCStone Pharmaceuticals Reports 2024 Interim Results and Business Updates SUZHOU, China, Aug. 25, 2024 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, … WebAlso Known As 基石药业, Jishi Yaoye. Legal Name CStone Pharmaceuticals Co., Ltd. Stock Symbol HKG:2616. Company Type For Profit. Contact Email [email protected]. Phone Number + 86- …
WebFeb 24, 2024 · CStone Pharmaceuticals is a China-based investment holding company. Through its subsidiaries, the Company is primarily engaged in development, …
WebNov 21, 2024 · CStone Pharmaceuticals (HKEX: 2616) is a biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology and precision medicines to address the unmet ... the barrton delray beachWebJun 4, 2024 · The collaboration strengthens CStone Pharmaceuticals' portfolio with exclusive rights in the territory to three clinical-stage targeted therapies and expands Blueprint Medicines' global efforts to ... the habsburg familyWebMar 23, 2024 · Dublin, March 23, 2024 (GLOBE NEWSWIRE) -- The "Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2024" report has been added to ... the habsburg empire tv showWebFind the latest Cstone Pharmaceuticals Co. Ltd. (KYG2588M1006.SG) stock quote, history, news and other vital information to help you with your stock trading and investing. the habsburgerWebApr 4, 2024 · INTRODUCTION. KEYNOTE-042 is a randomized phase III study that showed significantly longer overall survival (OS) with pembrolizumab monotherapy versus platinum-based chemotherapy in patients with previously untreated locally advanced or metastatic non–small-cell lung cancer (NSCLC) with programmed death ligand-1 (PD-L1) tumor … the bar royal glen huntlyWebCStone Pharmaceuticals is a biopharma company focused on developing and commercializing innovative immuno-oncology and molecularly targeted drugs to address … TIBSOVO ® is an oral targeted IDH1 inhibitor. The NMPA of China has … Suzhou, China, March 20th, 2024--CStone Pharmaceuticals (HKEX: 2616), a … Compared to western countries, China is a late starter in clinical development, and … Your privacy is important for us. We use cookies to enhance your experience … CStone Pharmaceuticals (HKEX: 2616) is a biopharmaceutical company focused on … Medical Information Consultant Joy Type：Medical Information Consultant … CStone Suzhou Translational Medicine Research Center (TMRC) is a cutting … Sugemalimab is an investigational anti-PD-L1 monoclonal antibody discovered by … Address: 21/F, No. 399, West Haiyang Road, New Bund Times Square, … the barrum reserves rumWebApr 4, 2024 · -- CStone Pharmaceuticals zegt dat de resultaten van zijn registrerende klinische studie naar sugemalimab voor de behandeling van lymfeklierkanker zijn gepubliceerd in het Journal of Clinical... 10 april 2024 the habsburgs andrew wheatcroft